Search results
Judge won't block Mississippi law on discounts for hospitals' contract pharmacies
Reuters· 6 days agoA federal judge in Mississippi on Monday refused to block a Mississippi law requiring drugmakers to...
Swiss Dividend Stocks To Consider In July 2024
Simply Wall St. via Yahoo Finance UK· 7 days agoDespite a generally positive trading day, the Swiss market closed slightly lower last Friday, reflecting investor caution as they processed regional...
Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
Benzinga via Yahoo Finance UK· 2 days agoNovo Nordisk A/S (NYSE:NVO), the maker of the popular obesity drug Ozempic, has been reprimanded by...
Mesoblast (MESO) Soars 208% YTD on Positive Regulatory Updates
Zacks via Yahoo Finance UK· 6 days agoJakafi is a first-in-class JAK1/JAK2 inhibitor. INCY has a collaboration agreement with the Swiss...
Exploring Dividend Stocks: Avoid OC Oerlikon In Favor Of One Better Option
Simply Wall St. via Yahoo Finance UK· 3 days agoInvestors often look to dividend stocks as a reliable source of income. However, it's essential to...
PeptiDream Leads Trio Of Japanese Growth Companies With High Insider Ownership
Simply Wall St. via Yahoo Finance UK· 7 days agoJapan's stock markets have shown resilience, with the Nikkei 225 and TOPIX indices experiencing...
Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer...
Benzinga via Yahoo Finance UK· 3 days agoOn Thursday, Roche Holdings AG (OTC:RHHBY) said that the Phase 2/3 SKYSCRAPER-06 study of...
Council Post: A Guide To French Business Immigration: The Talent Passport Program
Forbes· 3 days agoFrance offers a rich cultural tapestry, a cosmopolitan environment and enviable weather. As the EU’s...
3 High-Performing Swiss Dividend Stocks Yielding Up To 4.9%
Simply Wall St. via Yahoo Finance UK· 4 days agoThe Switzerland market has recently exhibited a pattern of cautious optimism, with the SMI index...
ESR1 Mutated Metastatic Breast Cancer Diagnostics Market is expected to grow at a CAGR of 11% and re
PharmiWeb· 4 days agoThe fight against breast cancer receives a crucial boost with advancements in diagnostic tools. Future Market Insights predicts the ESR1 Mutated Metastatic Breast Cancer Diagnostics Market to ...